Investigaion about the mRNA expression of ASB2 and Jak3 in patients with acute lymphoblastic leuke-mia
10.3760/cma.j.issn.1673-422X.2016.07.008
- VernacularTitle:急性淋巴细胞白血病患者 ASB2和 Jak3基因mRNA 表达的研究
- Author:
Yayun DENG
;
Wei WU
;
Ping′an ZHANG
;
- Publication Type:Journal Article
- Keywords:
Leukemia,lymphoid;
Bone marrow;
Polymerase chain reaction;
Ankyrin-repeat SOCS box containing protein 2;
Janus kinase 3
- From:
Journal of International Oncology
2016;43(7):515-518
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the expression of ankyrin-repeat SOCS box containing protein 2 (ASB2)and Janus kinase 3 (Jak3)mRNA in bone marrow plasma mononuclear cells of patients with acute lymphoblastic leukemia (ALL)and discuss the correlation of them.Methods Bone marrow plasma was collected from 48 patients of newly diagnosed ALL (37 cases B-ALL and 11 cases T-ALL)and 34 non leukemia patients (control group),respectively.Expression levels of ASB2 and Jak3 mRNA were detected by real-time quantitative PCR.Results The expression of ASB2 mRNA in B-ALL and T-ALL were significantly different compared to control group (t =14.2,P <0.01;t =15.2,P <0.01),which were 68.5,32.7 folded more than control group,respectively.Moreover,the expression level of Jak3 mRNA in B-ALL group and T-ALL group were 2 336.1 and 7 131.5 folded more than control group (t =37.3,P <0.01;t =37.6,P <0.01). At last,the expression of ASB2 and Jak3 gene was positive correlation (r =0.523,P <0.001).Conclusion ASB2 and Jak3 are expressed abnormally in ALL patients and the correlation of them is positive.ASB2 and Jak3 may be related to the proliferation and differentiation in leukemia cells.